Additional file 1: of Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

Table S1. Search Strategy. Table S2. Patient–related Multivariate Risk Factors of Acquistion of MDR P. aeruginosa. Table S3. Antibiotic Treatment–related Multivariate Risk Factors of Acquistion of MDR P. aeruginosa. Table S4. Other Treatment–related Multivariate Risk Factors of Acquistion of MDR and XDR P. aeruginosa. Table S5. Hospital–related Multivariate Risk Factors of Acquistion of MDR and XDR P. aeruginosa. Table S6. Patient–related Multivariate Risk Factors of Acquistion of Carbapenem-resistant P. aeruginosa. Table S7. Antibiotic Treatment–related Multivariate Risk Factors of Acquistion of Carbapenem-resistant P. aeruginosa. Table S8. Other Treatment–related Multivariate Risk Factors of Acquistion of Carbapenem-resistant P. aeruginosa. Table S9. Hospital–related Multivariate Risk Factors of Acquistion of Carbapenem-resistant P. aeruginosa. Table S10. Multivariate Risk Factors of Acquistion of Resistant P. aeruginosa. Figure S1. Meta-analysis of Risk Factors for Carbapenem versus Susceptible P. aeruginosa Acquisition. Figure S2. Meta-analysis of Prior Use of Carbapenem as a Risk Factor for Carbapenem versus Susceptible P. aeruginosa Acquisition. Figure S3. Meta-analysis of Prior Use of Fluoroquinolones as a Risk Factor for Quinolone-resistant versus Susceptible P. aeruginosa Acquisition. (DOCX 182 kb)